文献速递心脑血管急症呼吸衰竭与机械通气

早期医生随访与急性心肌梗死、充血性心力衰竭或慢性阻塞性肺疾病住院患者再入院的相关性

Association of Early Physician Follow-up With Readmission Among Patients Hospitalized for Acute Myocardial Infarction, Congestive Heart Failure, or Chronic Obstructive Pulmonary Disease.
PubMed 文献 · JAMA Netw Open · 2022-07-01
一句话结论在安大略省住院的急性心肌梗死、充血性心力衰竭或慢性阻塞性肺疾病患者中,出院后7天内早期医生随访与心力衰竭和慢性阻塞性肺疾病患者90天再入院率降低相关,但30天内及急性心肌梗死患者未见显著获益。

这项在加拿大安大略省开展的队列研究纳入2005至2019年间首次因急性心肌梗死、充血性心力衰竭或慢性阻塞性肺疾病住院的450746例成人患者,评估出院后7天内由初级保健医生或相关专科医生随访与30天和90天再入院的相关性。采用Cox比例风险模型,调整社会人口学因素和合并症,并按倾向评分重叠权重加权。结果显示,早期随访与心力衰竭患者90天再入院率降低(aHR 0.98;95% CI 0.96-0.99)和慢性阻塞性肺疾病患者90天再入院率降低(aHR 0.95;95% CI 0.93-0.98)相关,慢性阻塞性肺疾病患者90天疾病特异性再入院率降低(aHR 0.93;95% CI 0.89-0.96),心力衰竭患者90天死亡率降低(aHR 0.93;95% CI 0.90-0.97)。30天内及急性心肌梗死患者未见显著获益。作者认为,早期随访结合全面的过渡期护理策略和持续有效的慢性病管理,可能与90天再入院率降低相关。

要点

  • 在加拿大安大略省2005至2019年首次因急性心肌梗死、充血性心力衰竭或慢性阻塞性肺疾病住院的450746例成人中,出院后7天内早期医生随访与心力衰竭患者90天再入院率降低相关(aHR 0.98;95% CI 0.96-0.99)。
  • 慢性阻塞性肺疾病患者中,早期随访与90天再入院率降低相关(aHR 0.95;95% CI 0.93-0.98),并与90天慢性阻塞性肺疾病相关再入院率降低相关(aHR 0.93;95% CI 0.89-0.96)。
  • 心力衰竭患者中,早期随访与90天死亡率降低相关(aHR 0.93;95% CI 0.90-0.97)。
  • 30天内及急性心肌梗死患者中,早期随访未见显著获益。
  • 作者认为,早期随访结合全面的过渡期护理策略和持续有效的慢性病管理,可能与90天再入院率降低相关。

适用人群与场景

  • 加拿大安大略省2005至2019年间首次因急性心肌梗死、充血性心力衰竭或慢性阻塞性肺疾病住院的成人患者,共450746例,包括急性心肌梗死198854例、充血性心力衰竭133058例、慢性阻塞性肺疾病118834例。
  • 中位(IQR)年龄:急性心肌梗死66(56-77)岁,充血性心力衰竭78(68-85)岁,慢性阻塞性肺疾病73(64-81)岁;女性分别64339例(32.35%)、62575例(47.03%)、59179例(49.80%)。

研究设计与关键结果

  • 研究类型为队列研究,纳入加拿大安大略省2005至2019年间首次因急性心肌梗死、充血性心力衰竭或慢性阻塞性肺疾病住院的成人患者450746例。
  • 暴露为出院后7天内由初级保健医生或相关专科医生进行的随访访视;采用Cox比例风险模型比较有与无早期随访的患者,调整社会人口学因素和合并症,并按倾向评分重叠权重加权。
  • 接受早期随访的比例:急性心肌梗死91182例(45.85%),充血性心力衰竭56491例(42.46%),慢性阻塞性肺疾病40159例(33.79%)。
  • 早期随访组协作护理率更高(例如充血性心力衰竭:20931例[37.85%] vs 76567例中11101例[14.85%]),30天内专科就诊率更高(例如充血性心力衰竭:25797例[45.67%] vs 20548例[26.84%])。
  • 充血性心力衰竭患者中,早期随访组90天再入院率更低(15934例[28.21%] vs 23121例[30.20%];aHR 0.98;95% CI 0.96-0.99)。
  • 慢性阻塞性肺疾病患者中,早期随访组90天再入院率更低(8784例[21.87%] vs 78675例中18097例[23.00%];aHR 0.95;95% CI 0.93-0.98)。
  • 慢性阻塞性肺疾病患者中,早期随访组90天慢性阻塞性肺疾病相关再入院率更低(4015例[10.00%] vs 8449例[10.74%];aHR 0.93;95% CI 0.89-0.96)。
  • 充血性心力衰竭患者中,早期随访组90天死亡率更低(4044例[7.16%] vs 6281例[8.20%];aHR 0.93;95% CI 0.90-0.97)。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,早期随访结合全面的过渡期护理策略和持续有效的慢性病管理,可能与90天再入院率降低相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: A better understanding of the association between early physician follow-up after discharge and adverse outcomes among hospitalized patients may inform interventions aimed at reducing readmission for common chronic conditions.

OBJECTIVE: To assess whether hospitalized patients with early physician follow-up after discharge had lower rates of overall and condition-specific readmissions within 30 days and 90 days of discharge.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted among Ontario, Canada, adults with first admission for acute myocardial infarction (AMI), congestive heart failure (CHF), or chronic obstructive pulmonary disease (COPD) during 2005 to 2019. The exposure was follow-up visit with a primary care physician or relevant specialist within 7 days of discharge. Cox proportional hazards models were used to compare patients with vs without early follow-up, adjusting for sociodemographic factors and comorbidities, weighting by propensity score-based overlap weights. Data were analyzed from January through July 2021.

MAIN OUTCOMES AND MEASURES: Primary outcomes were 30-day and 90-day readmissions, cardiac readmissions (readmission for AMI, CHF, or angina) for patients with cardiac conditions, and COPD-related readmissions for patients with COPD. Mortality at 30 days and 90 days was a secondary outcome. All percentages reported in Results are unweighted.

RESULTS: The study cohort comprised 450 746 patients, including 198 854 patients with AMI, 133 058 patients with CHF, and 118 834 patients with COPD; the median (IQR) age was 66 (56-77) years for AMI, 78 (68-85) years for CHF, and 73 (64-81) years for COPD, and there were 64 339 (32.35%) women, 62 575 (47.03%) women, and 59 179 (49.80%) women, respectively. There were 91 182 patients (45.85%), 56 491 patients (42.46%), and 40 159 patients (33.79%), respectively, who received an early follow-up visit. Overall, patients with early follow-up had higher rates of collaborative care (eg, CHF: 20 931 patients [37.85%] vs 11 101 of 76 567 patients [14.85%]) and visits to a specialist within 30 days (eg, CHF: 25 797 patients [45.67%] vs 20 548 patients [26.84%]). Those with early follow-up had lower 90-day readmission rates among patients with CHF (15 934 patients [28.21%] vs 23 121 patients [30.20%]; adjusted hazard ratio [aHR], 0.98; 95% CI, 0.96-0.99) and among those with COPD (8784 patients [21.87%] vs 18 097 of 78 675 patients [23.00%]; aHR, 0.95; 95% CI, 0.93-0.98). Among patients with COPD, those with early follow-up had lower 90-day COPD-related readmission rates (4015 patients [10.00%] vs 8449 patients [10.74%]; aHR, 0.93; 95% CI, 0.89-0.96), and among patients with CHF, those with early follow-up had lower 90-day mortality rates (4044 patients [7.16%] vs 6281 patients [8.20%]; aHR, 0.93; 95% CI, 0.90-0.97). There were no significant benefits at 30 days or for patients with AMI.

CONCLUSIONS AND RELEVANCE: These findings suggest that early follow-up in conjunction with a comprehensive transitional care strategy for hospitalized patients with medically complex conditions coupled with ongoing effective chronic disease management may be associated with reduced 90-day readmissions.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Saxena FE, Bierman AS, Glazier RH, et al. Association of Early Physician Follow-up With Readmission Among Patients Hospitalized for Acute Myocardial Infarction, Congestive Heart Failure, or Chronic Obstructive Pulmonary Disease. JAMA Netw Open. 2022. PMID: 35819782. doi:10.1001/jamanetworkopen.2022.22056

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。